Data as of 10:10am ET
| -1.20 / -1.77%|
The 5 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 86.00, with a high estimate of 109.41 and a low estimate of 84.00. The median estimate represents a +29.28% increase from the last price of 66.52.
The current consensus among 5 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.